ClinicalTrials.Veeva

Menu

Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

V

Vachira Phuket Hospital

Status

Completed

Conditions

Covid-19

Treatments

Diagnostic Test: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)

Study type

Interventional

Funder types

Other

Identifiers

NCT06259656
VPH REC 009/2023

Details and patient eligibility

About

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.

Full description

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.

Enrollment

40 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Thai term pregnant women
  • 18-45 year old
  • At least 1 covid vaccination received
  • admission at Vachira Phuket Hospital Labor Room

Exclusion criteria

  • Do not want to participate
  • Unstable or Emergency condition

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Thai term pregnant woman who have at least One dose of Covid vaccination
Other group
Description:
Maternal and cord blood was collected to test COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
Treatment:
Diagnostic Test: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)

Trial contacts and locations

1

Loading...

Central trial contact

Ratikorn Saejong, M.D.; Montree Boonyakitanon, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems